Literature DB >> 15016554

A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer.

Sang Taek Oh1, Jung Seon Seo, Uk Yeol Moon, Kyeong Hee Kang, Dong-Jik Shin, Sungjoo Kim Yoon, Woo Ho Kim, Jae-Gahb Park, Suk Kyeong Lee.   

Abstract

In a process seeking out a good model cell line for Epstein-Barr virus (EBV)-associated gastric cancer, we found that one previously established gastric adenocarcinoma cell line is infected with type 1 EBV. This SNU-719 cell line from a Korean patient expressed cytokeratin without CD19 or CD21 expression. In SNU-719, EBNA1 and LMP2A were expressed, while LMP1 and EBNA2 were not. None of the tested lytic EBV proteins were detected in this cell line unless stimulated with phorbol ester. EBV infection was also shown in the original carcinoma tissue of SNU-719 cell line. Our results support the possibility of a CD21-independent EBV infection of gastric epithelial cells in vivo. As the latent EBV gene expression pattern of SNU-719 closely resembles that of the EBV-associated gastric cancer, this naturally derived cell line may serve as a valuable model system to clarify the precise role of EBV in gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016554     DOI: 10.1016/j.virol.2003.12.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  37 in total

1.  Association between Epstein-Barr virus infection and chemoresistance to docetaxel in gastric carcinoma.

Authors:  Hee Jong Shin; Do Nyun Kim; Suk Kyeong Lee
Journal:  Mol Cells       Date:  2011-05-27       Impact factor: 5.034

2.  Establishment and characterization of six human gastric carcinoma cell lines, including one naturally infected with Epstein-Barr virus.

Authors:  Ja-Lok Ku; Kyung-Hee Kim; Jin-Sung Choi; Sung-Hee Kim; Young-Kyoung Shin; Hee Jin Chang; Jae-Moon Bae; Young-Woo Kim; Jun Ho Lee; Han-Kwang Yang; Woo-Ho Kim; Seung-Yong Jeong; Jae-Gahb Park
Journal:  Cell Oncol (Dordr)       Date:  2012-02-24       Impact factor: 6.730

3.  MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.

Authors:  Yu-Jin Jung; Hoyun Choi; Hyoji Kim; Suk Kyeong Lee
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

4.  Epstein-Barr Virus-Induced Nodules on Viral Replication Compartments Contain RNA Processing Proteins and a Viral Long Noncoding RNA.

Authors:  Richard Park; George Miller
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

5.  Relationship between abnormality of FHIT gene and EBV infection in gastric cancer.

Authors:  Yu-Ping Xiao; Cheng-Bo Han; Xiao-Yun Mao; Jin-Yi Li; Lei Xu; Chang-Shan Ren; Yan Xin
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

6.  Chimerically fused antigen rich of overlapped epitopes from latent membrane protein 2 (LMP2) of Epstein-Barr virus as a potential vaccine and diagnostic agent.

Authors:  Xiaoyun Lin; Shao Chen; Xiangyang Xue; Lijun Lu; Shanli Zhu; Wenshu Li; Xiangmin Chen; Xiaozhi Zhong; Pengfei Jiang; Torsoo Sophia Sename; Yi Zheng; Lifang Zhang
Journal:  Cell Mol Immunol       Date:  2015-04-13       Impact factor: 11.530

7.  Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma.

Authors:  Do Nyun Kim; Hiun-Suk Chae; Sang Taek Oh; Jin-Hyoung Kang; Cho Hyun Park; Won Sang Park; Kenzo Takada; Jae Myun Lee; Won-Keun Lee; Suk Kyeong Lee
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

Review 8.  Recapitulating Human Gastric Cancer Pathogenesis: Experimental Models of Gastric Cancer.

Authors:  Lin Ding; Mohamad El Zaatari; Juanita L Merchant
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

9.  Biology of SNU cell lines.

Authors:  Ja-Lok Ku; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

10.  Epstein-Barr virus and gastric carcinoma--viral carcinogenesis through epigenetic mechanisms.

Authors:  Hiroshi Uozaki; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.